Bloomberg Intelligence on the Frontiers of Cancer Research

Sam Fazeli discusses the evolution of cancer treatment over the past 20 years, highlighting advancements from chemotherapy to targeted therapies and immunotherapy. He addresses the challenges of health inequities and the high costs of modern treatments, emphasizing the need for accessible cancer care worldwide.

What advancements in cancer treatment have been made with antibodies?

What is the significance of immunotherapy in the treatment of melanoma?

What challenges do poorer countries face in accessing modern cancer treatments?